Spots Global Cancer Trial Database for Breast, Omega 3 Free Fatty Acid, Ph 0
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Breast, Omega 3 Free Fatty Acid, Ph 0
Official Title: A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)
Study ID: NCT02996240
Conditions
Interventions
Study Description
Brief Summary: Assess the impact of dietary omega 3 free fatty acids breast cancer patients.
Detailed Description: Prospective, single arm, short term study with correlative biomarker endpoints. Two hundred (200) newly diagnosed breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection. Patients will be receive fish Oil (Omega-3 FFAs, 2700 mg by mouth twice daily).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CTRC at University of Texas Health Science Center San Antonio, San Antonio, Texas, United States
Contact Details
Name: Virginia G Kaklamani, MD
Affiliation: Principal Investigator
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
